ResearchGate Restricts Access to Nearly 2 Million Articles

The academic social network is bending to pressure from publishing giants that demand it removes copyrighted material from its site.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, PERE_RUBIClarification (November 10): The 1.7 million figure cited in this article was first published on Twitter on November 1 by Nature's Richard Van Noorden following a phone conversation with CRS spokesman James Milne. This figure was also cited by Nature on November 8.

The academic social network ResearchGate has taken moves to restrict access to at least 1.7 million scholarly articles following threats of legal action by a coalition of publishers including Elsevier and the American Chemical Society (ACS), Times Higher Education reports today (November 9). The change, which follows months of conflict between the organizations, means that papers once freely available to download now have to be requested directly from their authors.

“ResearchGate’s primary service is taking high-quality content written and published by others and making as many as 7 million copyrighted articles—40% of its total content—freely available via its for-profit platform,” the Coalition for Responsible Sharing, a collaboration formed between ACS, Brill, Elsevier, Wiley, and Wolters Kluwer, writes in a statement published on October 5. “Numerous attempts to agree with ResearchGate on amicable solutions . . . remained unsuccessful. Members of the Coalition for Responsible Sharing are therefore now resorting to formal means to alter ResearchGate’s damaging practices.”

On October 6, two of the Coalition’s members—Elsevier and ACS—filed a lawsuit in Germany to prevent the Berlin-based paper-sharing site from hosting copyrighted material in the future. Around the same time, an initial batch of “take-down notices” was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies